Correlation Engine 2.0
Clear Search sequence regions


  • CD34 (10)
  • CD56 (1)
  • cell count (4)
  • disease risk (1)
  • disease wbc (1)
  • free (2)
  • gene fusion (2)
  • leukemia (8)
  • myelofibrosis (1)
  • necrosis (1)
  • patients (5)
  • PML (2)
  • poor prognosis (1)
  • prognosis (3)
  • RARa (1)
  • RARα (1)
  • volunteers (1)
  • Sizes of these terms reflect their relevance to your search.

    Our previous work has demonstrated that some acute promyelocytic leukemia (APL) patients had significantly elevated circulating CD34+ cell count (≥ 10 × 106/L), and these patients with higher CD34+ cell level usually presented with high-risk disease (WBC > 10,000/μL). The aim of this study was to investigate whether circulating CD34+ cell count is a prognostic marker in intermediate-low risk APL patients. In this study, 76 intermediate-low risk APL patients and 56 age-adjusted healthy volunteers were evaluated. Enumeration of CD34+ cells was investigated before the treatment. A cut-off value of 10 × 106/L CD34+ cells could just distinguish APL patients with adverse prognostic factors from others and may have the power to predict shorter progression-free survival (PFS) and poor prognosis. Higher count of CD34+ cells was usually associated with nonclassical chromosomal translocation, PML/RARα gene complex fusion, APL history, chemotherapy-related APL, disease progression, second tumor, extramedullary infiltration, FLT3-ITD positive mutation, atypical morphology, BM promyelocyte CD56/CD34 positive expression, myelofibrosis, PCR-positive PML/RARa gene fusion but FISH-negative, marrow necrosis and shorter PFS. Our results suggest that the level of CD34+ cells can be further the stratification of disease risk, a higher CD34+ cell count may be indicative of inferior survival and serve as an adverse biomarker for intermediate-low risk APL. © Indian Society of Hematology and Blood Transfusion 2019.

    Citation

    Cuiling Zhang, Haibo Dong, Yipeng Lin, Peipei Xu, Rongfu Zhou, Hui Zeng. Higher Level of Peripheral Blood CD34 Positive Cells Presented with Unfavorable Prognosis in Intermediate-Low Risk Acute Promyelocytic Leukemia. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 2020 Apr;36(2):309-315


    PMID: 32425382

    View Full Text